DK1296651T3 - Fremgangsmåde til fremstilling af partikler til anvendelse i et farmaceutisk præparat - Google Patents

Fremgangsmåde til fremstilling af partikler til anvendelse i et farmaceutisk præparat

Info

Publication number
DK1296651T3
DK1296651T3 DK01947612T DK01947612T DK1296651T3 DK 1296651 T3 DK1296651 T3 DK 1296651T3 DK 01947612 T DK01947612 T DK 01947612T DK 01947612 T DK01947612 T DK 01947612T DK 1296651 T3 DK1296651 T3 DK 1296651T3
Authority
DK
Denmark
Prior art keywords
particles
preparation
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
DK01947612T
Other languages
Danish (da)
English (en)
Inventor
David Alexander Vodden Morton
John Nicholas Staniforth
Rosella Musa
Original Assignee
Vectura Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0029263A external-priority patent/GB0029263D0/en
Priority claimed from PCT/GB2001/001732 external-priority patent/WO2001078694A2/en
Application filed by Vectura Ltd filed Critical Vectura Ltd
Priority claimed from PCT/GB2001/002860 external-priority patent/WO2002000197A1/en
Application granted granted Critical
Publication of DK1296651T3 publication Critical patent/DK1296651T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK01947612T 2000-06-27 2001-06-27 Fremgangsmåde til fremstilling af partikler til anvendelse i et farmaceutisk præparat DK1296651T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP00113608 2000-06-27
GB0029263A GB0029263D0 (en) 2000-11-30 2000-11-30 Method of making particles for use in a pharmaceutical composition
PCT/GB2001/001732 WO2001078694A2 (en) 2000-04-17 2001-04-17 Formulations for use in inhaler devices
PCT/GB2001/002860 WO2002000197A1 (en) 2000-06-27 2001-06-27 Method of making particles for use in a pharmaceutical composition

Publications (1)

Publication Number Publication Date
DK1296651T3 true DK1296651T3 (da) 2008-02-11

Family

ID=27223055

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01947612T DK1296651T3 (da) 2000-06-27 2001-06-27 Fremgangsmåde til fremstilling af partikler til anvendelse i et farmaceutisk præparat

Country Status (5)

Country Link
JP (1) JP5698423B2 (https=)
AU (2) AU2001269261B2 (https=)
CA (1) CA2413692C (https=)
DE (1) DE60131399T3 (https=)
DK (1) DK1296651T3 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8623405B2 (en) * 2005-01-28 2014-01-07 Takeda Pharmaceutical Company Limited Finely divided composition containing poorly water soluble substance
ITMI20051999A1 (it) 2005-10-21 2007-04-22 Eratech S R L Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita'
WO2011131663A1 (en) * 2010-04-21 2011-10-27 Chiesi Farmaceutici S.P.A. "process for providing particles with reduced electrostatic charges"
RU2666963C2 (ru) * 2012-04-13 2018-09-13 Глаксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед Агрегированные частицы
HUE053957T2 (hu) * 2013-07-11 2021-08-30 Chiesi Farm Spa Antikolinerg, kortikoszteroid és béta-adrenerg anyagot tartalmazó száraz porkészítmény inhalálással történõ beadásra
MA40910A (fr) * 2014-11-07 2017-09-12 Civitas Therapeutics Inc Poudres de rapamycine pour administration pulmonaire
WO2019009335A1 (ja) * 2017-07-04 2019-01-10 村上 正裕 微粒子の製造方法及び微粒子

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1204826B (it) * 1986-03-04 1989-03-10 Chiesi Farma Spa Composizioni farmaceutiche per inalazione
SE8603812D0 (sv) * 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
DE3917617A1 (de) * 1989-05-31 1990-12-06 Boehringer Ingelheim Kg Mikronisierte bioabbaubare partikel, verfahren zur ihrer herstellung und ihre verwendung
GB2269992A (en) * 1992-08-14 1994-03-02 Rh Ne Poulenc Rorer Limited Powder inhalation formulations
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9515182D0 (en) * 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
DE69732306T2 (de) * 1997-01-16 2006-01-12 Massachusetts Institute Of Technology, Cambridge Zubereitung von partikelhaltigen arzneimitteln zur inhalation
DK1064942T3 (da) * 1998-03-26 2004-11-01 Fujisawa Pharmaceutical Co Sustained release-fremstilling af et makrolid
AU756852B2 (en) * 1998-11-13 2003-01-23 Jagotec Ag Dry powder for inhalation
GB9826783D0 (en) * 1998-12-04 1999-01-27 Scherer Ltd R P Inhalation powders
GB9827145D0 (en) * 1998-12-09 1999-02-03 Co Ordinated Drug Dev Improvements in or relating to powders

Also Published As

Publication number Publication date
JP2004501183A (ja) 2004-01-15
CA2413692A1 (en) 2002-01-03
AU6926101A (en) 2002-01-08
DE60131399D1 (de) 2007-12-27
JP5698423B2 (ja) 2015-04-08
DE60131399T3 (de) 2019-11-14
AU2001269261B2 (en) 2005-11-17
CA2413692C (en) 2011-10-18
DE60131399T2 (de) 2008-04-17

Similar Documents

Publication Publication Date Title
AU2211502A (en) Method of making particles for use in a pharmaceutical composition
DK1158992T3 (da) Anvendelse af xenon til fremstilling af et farmaceutisk præparat til behandling af neurointoksikationer
ATE279961T1 (de) Neue pharmazeutische zusammensetzung
DK1349580T3 (da) Fremgangsmåde til forbedring af stabiliteten af en farmaceutisk sammensætning
ATE468324T1 (de) Pharmazeutische zusammensetzung
ATE404180T1 (de) Geschmacksmaskierte pharmazeutische partikel
HUP0303078A3 (en) Cyclic peptidies process for their preparation pharmaceutical compositions containing them and their use
EP1458362A4 (en) PHARMACEUTICAL COMPOSITIONS IN PARTICULAR FORM
AT7729U3 (de) Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat
NO20025450L (no) Ny farmasöytisk sammensetning
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
FI20001750A0 (fi) Farmaseuttisia koostumuksia
DK1383482T3 (da) Fremgangsmåde til fremstilling af en farmaceutisk lavdoseringssammensætning
EE05020B1 (et) Glburiidi ravimkoostis
DK1309545T3 (da) Fremgangsmåde til fremstilling af alkylarylsulfonater
HUP0302130A3 (en) Combination pharmaceutical compositions and process for their preparation
AP2002002575A0 (en) Compounds having hypolupedemic and hypocholestermic activities process for their preparation and pharmaceutical compositions containing them
HUP0300539A3 (en) New pharmaceutical composition in form of emulsion preconcentrate
ATE366128T1 (de) Pharmazeutische zusammensetzung
ATE350016T1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
DK1296651T3 (da) Fremgangsmåde til fremstilling af partikler til anvendelse i et farmaceutisk præparat
DK1326836T3 (da) Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin
ATE222586T1 (de) Benzolsulfonamidderivate und verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
NO20030156L (no) Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
FR2797401B1 (fr) Composition pharmaceutique anti-ulcere et sa preparation